On May 13, 2026 Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, reported that management will participate in the following upcoming investor conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2026 Stifel Virtual Targeted Oncology Forum: Zymeworks’ management will participate in one-on-one meetings and a fireside chat on May 20 at 9:00 am Eastern Time (ET) virtually.
TD Cowen 7th Annual Oncology Innovation Summit: Zymeworks’ management will participate in a fireside chat on May 27 at 4:30 pm ET virtually.
2026 Jefferies Global Healthcare Conference: Zymeworks’ management will participate in one-on-one meetings and a fireside chat on June 3 at 8:45 am ET in New York, NY.

(Press release, Zymeworks, MAY 13, 2026, View Source [SID1234665662])